The impact of epilepsy on patients' lives

Acta Neurologica Scandinavica

Volumn 126, Issue S194, 2012, Pages 1-9

  Kerr, M P ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Antiepileptic drug; Comorbidity; Epilepsy; Functional status; Patient survey; Quality of life; Side effects

Indexed keywords

ANTICONVULSIVE AGENT;

AGITATED DEPRESSION; ANTICONVULSANT THERAPY; ANXIETY DISORDER; ASTHMA; AWARENESS; BEHAVIOR DISORDER; BRAIN CONCUSSION; BURN; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; COMORBIDITY; CONSULTATION; DAILY LIFE ACTIVITY; DEPRESSION; DIGESTIVE SYSTEM FUNCTION DISORDER; DOCTOR PATIENT RELATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EPILEPSY; FATIGUE; FRACTURE; FUNCTIONAL STATUS; HEALTH STATUS; HEALTH SURVEY; HEARING IMPAIRMENT; HOLISTIC CARE; HOSPITALIZATION; HUMAN; INJURY; INTRACTABLE EPILEPSY; MEMORY DISORDER; MENTAL CONCENTRATION; MENTAL DISEASE; MENTAL HEALTH; MORTALITY; MULTICENTER STUDY (TOPIC); NERVOUSNESS; PANIC; PATIENT ASSESSMENT; PATIENT CARE; PHYSICIAN; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; REVIEW; RISK FACTOR; RISK REDUCTION; SCREENING TEST; SEIZURE; SIDE EFFECT; SOCIOECONOMICS; SOMNOLENCE; SPRAIN; STANDARDIZED MORTALITY RATIO; STRESS; SUDDEN DEATH; SUICIDE; THINKING IMPAIRMENT; TONIC CLONIC SEIZURE; VISUAL IMPAIRMENT; TREATMENT OUTCOME;

ANTICONVULSANTS; COMORBIDITY; EPILEPSY; HUMANS; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 84875961025     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/ane.12014     Document Type: Review

References (92)

1. de Boer HM, Mula M, Sander JW. The global burden and stigma of epilepsy. Epilepsy Behav 2008;12:540-6.
2. Kessler RC, Lane MC, Shahly V, Stang PE. Accounting for comorbidity in assessing the burden of epilepsy among US adults: results from the National Comorbidity Survey Replication (NCS-R). Mol Psychiatry 2012;17:748-58.
3. Beghi E, Cornaggia C; RESt-1 Group. Morbidity and accidents in patients with epilepsy: results of a European cohort study. Epilepsia 2002;43:1076-83.
4. van den Broek M, Beghi E;RESt-1 Group. Accidents in patients with epilepsy: types, circumstances, and complications: a European cohort study. Epilepsia 2004;45:667-72.
5. Lawn ND, Bamlet WR, Radhakrishnan K, O'Brien PC, So EL. Injuries due to seizures in persons with epilepsy: a population-based study. Neurology 2004;63:1565-70.
6. Téllez-Zenteno JF, Hunter G, Wiebe S. Injuries in people with self-reported epilepsy: a population-based study. Epilepsia 2008;49:954-61.
7. Nguyen R, Téllez Zenteno JF. Injuries in epilepsy: a review of its prevalence, risk factors, type of injuries and prevention. Neurol Int 2009;1:e20.
8. Asadi-Pooya AA, Nikseresht A, Yaghoubi E, Nei M. Physical injuries in patients with epilepsy and their associated risk factors. Seizure 2011;21:165-8.
9. Dunn DW, Austin JK, Harezlak J, Ambrosius WT. ADHD and epilepsy in childhood. Dev Med Child Neurol 2003;45:50-4.
10. Swensen A, Birnbaum HG, Ben Hamadi R, Greenberg P, Cremieux PY, Secnik K. Incidence and costs of accidents among attention-deficit/hyperactivity disorder patients. J Adolesc Health 2004;35:346.e1-9.
11. Eddy CM, Rickards HE, Cavanna AE. The cognitive impact of antiepileptic drugs. Ther Adv Neurol Disord 2011;4:385-407.
12. Tomson T, Beghi E, Sundqvist A, Johannessen SI. Medical risks in epilepsy: a review with focus on physical injuries, mortality, traffic accidents and their prevention. Epilepsy Res 2004;60:1-16.
13. Beghi E. Accidents and injuries in patients with epilepsy. Expert Rev Neurother 2009;9:291-8.
14. Mattson RH, Gidal BE. Fractures, epilepsy, and antiepileptic drugs. Epilepsy Behav 2004;5(Suppl. 2):S36-40.
15. Beerhorst K, Schouwenaars FM, Tan IY, Aldenkamp AP. Epilepsy: fractures and the role of cumulative antiepileptic drug load. Acta Neurol Scand 2012;125:54-9.
16. Svalheim S, Røste LS, Nakken KO, Taubøll E. Bone health in adults with epilepsy. Acta Neurol Scand Suppl 2011;191:89-95.
17. Hauser WA, Hesdorffer DC. Epilepsy: frequency, causes and consequences. Epilepsy Foundation of America: Landover, MD, 1990.
18. Currie CJ, Morgan CL, Peters JR, Kerr M. The demand for hospital services for patients with epilepsy. Epilepsia 1998;39:537-44.
19. Copeland LA, Ettinger AB, Zeber JE, Gonzalez JM, Pugh MJ. Psychiatric and medical admissions observed among elderly patients with new-onset epilepsy. BMC Health Serv Res 2011;11:84.
20. Cockerell OC, Johnson AL, Sander JW, Hart YM, Goodridge DM, Shorvon SD. Mortality from epilepsy: results from a prospective population-based study. Lancet 1994;344:918-21.
21. Lhatoo SD, Johnson AL, Goodridge DM, MacDonald BK, Sander JW, Shorvon SD. Mortality in epilepsy in the first 11 to 14 years after diagnosis: multivariate analysis of a long-term, prospective, population-based cohort. Ann Neurol 2001;49:336-44.
22. Forsgren L, Hauser WA, Olafsson E, Sander JW, Sillanpää M, Tomson T. Mortality of epilepsy in developed countries: a review. Epilepsia 2005;46(Suppl. 11):18-27.
23. Neligan A, Bell GS, Johnson AL, Goodridge DM, Shorvon SD, Sander JW. The long-term risk of premature mortality in people with epilepsy. Brain 2011;134:388-95.
24. Tomson T. Mortality in epilepsy. J Neurol 2000;247:15-21.
25. Tomson T, Walczak T, Sillanpaa M, Sander JW. Sudden unexpected death in epilepsy: a review of incidence and risk factors. Epilepsia 2005;46(Suppl. 11):54-61.
26. Bell GS, Sander JW. Sudden unexpected death in epilepsy. Risk factors, possible mechanisms and prevention: a reappraisal. Acta Neurol Taiwan 2006;15:72-83.
27. Surges R, Thijs RD, Tan HL, Sander JW. Sudden unexpected death in epilepsy: risk factors and potential pathomechanisms. Nat Rev Neurol 2009;5:492-504.
28. Lhatoo SD, Sander JW. Cause-specific mortality in epilepsy. Epilepsia 2005;46(Suppl. 11):36-9.
29. Kanner AM. Depression and epilepsy: a bidirectional relation? Epilepsia 2011;52(Suppl. 1):21-7.
30. Danzer SC. Depression, stress, epilepsy and adult neurogenesis. Exp Neurol 2012;233:22-32.
31. Thapar A, Kerr M, Harold G. Stress, anxiety, depression, and epilepsy: investigating the relationship between psychological factors and seizures. Epilepsy Behav 2009;14:134-40.
32. Frucht MM, Quigg M, Schwaner C, Fountain NB. Distribution of seizure precipitants among epilepsy syndromes. Epilepsia 2000;41:1534-9.
33. Turky A, Felce D, Jones G, Kerr M. A prospective case control study of psychiatric disorders in adults with epilepsy and intellectual disability. Epilepsia 2011;52:1223-30.
34. Taylor J, Kolamunnage-Dona R, Marson AG, Smith PE, Aldenkamp AP, Baker GA; SANAD study group. Patients with epilepsy: cognitively compromised before the start of antiepileptic drug treatment? Epilepsia 2010;51:48-56.
35. Dodrill CB. Progressive cognitive decline in adolescents and adults with epilepsy. Prog Brain Res 2002;135:399-407.
36. Wirrell EC. Epilepsy-related injuries. Epilepsia 2006;47(Suppl. 1):79-86.
37. Bautista RE, Glen ET. Seizure severity is associated with quality of life independent of seizure frequency. Epilepsy Behav 2009;16:325-9.
38. Sancho J, Iváñez V, Molins A, López Gómez V, Masramón X, Pérez M. Changes in seizure severity and quality of life in patients with refractory partial epilepsy. Epilepsy Behav 2010;19:409-13.
39. Loring DW, Meador KJ, Lee GP. Determinants of quality of life in epilepsy. Epilepsy Behav 2004;5:976-80.
40. Baker GA, Jacoby A, Buck D, Stalgis C, Monnet D. Quality of life of people with epilepsy: a European study. Epilepsia 1997;38:353-62.
41. World Health Organization. Epilepsy facts; http://www.who.int/mental_health/neurology/epilepsy/en/index.html (accessed 16 May 2012).
42. de Boer HM. Epilepsy stigma: moving from a global problem to global solutions. Seizure 2010;19:630-6.
43. Fernandes PT, Snape DA, Beran RG, Jacoby A. Epilepsy stigma: what do we know and where next? Epilepsy Behav 2011;22:55-62.
44. Reis R, Meinardi H. ILAE/WHO 'Out of the Shadows Campaign' stigma: does the flag identify the cargo? Epilepsy Behav 2002;3(Suppl. 2):33-7.
45. Jacoby A. Epilepsy and stigma: an update and critical review. Curr Neurol Neurosci Rep 2008;8:339-44.
46. Cramer JA, Blum D, Reed M, Fanning K; Epilepsy Impact Project Group. The influence of comorbid depression on quality of life for people with epilepsy. Epilepsy Behav 2003;4:515-21.
47. Gaitatzis A, Carroll K, Majeed A, Sander JW. The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia 2004;45:1613-22.
48. Pompili M, Girardi P, Ruberto A, Tatarelli R. Suicide in the epilepsies: a meta-analytic investigation of 29 cohorts. Epilepsy Behav 2005;7:305-10.
49. Tellez-Zenteno JF, Patten SB, Jetté N, Williams J, Wiebe S. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia 2007;48:2336-44.
50. Christensen J, Vestergaard M, Mortensen PB, Sidenius P, Agerbo E. Epilepsy and risk of suicide: a population-based case-control study. Lancet Neurol 2007;6:693-8.
51. Stefanello S, Marín-Léon L, Fernandes PT, Li LM, Botega NJ. Psychiatric comorbidity and suicidal behavior in epilepsy: a community-based case-control study. Epilepsia 2010;51:1120-5.
52. Kwon C, Liu M, Quan H, Thoo V, Wiebe S, Jetté N. Motor vehicle accidents, suicides, and assaults in epilepsy: a population-based study. Neurology 2011;76:801-6.
53. Beck AT, Brown G, Berchick RJ, Stewart BL, Steer RA. Relationship between hopelessness and ultimate suicide: a replication with psychiatric outpatients. Am J Psychiatry 1990;147:190-5.
54. Pompili M, Vanacore N, Macone S et al. Depression, hopelessness and suicide risk among patients suffering from epilepsy. Ann Ist Super Sanita 2007;43:425-9.
55. Kanner AM, Balabanov A. Depression and epilepsy: how closely related are they? Neurology 2002;58(Suppl. 5):S27-39.
56. Meador KJ. Suicide in patients with epilepsy. Epilepsy Curr 2008;8:40-2.
57. Gilliam FG, Barry JJ, Hermann BP, Meador KJ, Vahle V, Kanner AM. Rapid detection of major depression in epilepsy: a multicentre study. Lancet Neurol 2006;5:399-405.
58. Wiebe S, Hesdorffer DC. Epilepsy: being ill in more ways than one. Epilepsy Curr 2007;7:145-8.
59. Elliott JO, Lu B, Shneker B, Charyton C, Layne Moore J. Comorbidity, health screening, and quality of life among persons with a history of epilepsy. Epilepsy Behav 2009;14:125-9.
60. Manni R, Terzaghi M. Comorbidity between epilepsy and sleep disorders. Epilepsy Res 2010;90:171-7.
61. Brandt C, Schoendienst M, Trentowska M et al. Prevalence of anxiety disorders in patients with refractory focal epilepsy - a prospective clinic based survey. Epilepsy Behav 2010;17:259-63.
62. Cardarelli WJ, Smith BJ. The burden of epilepsy to patients and payers. Am J Manag Care 2010;16(12 Suppl.):S331-6.
63. Ottman R, Lipton RB, Ettinger AB et al. Comorbidities of epilepsy: results from the Epilepsy Comorbidities and Health (EPIC) survey. Epilepsia 2011;52:308-15.
64. Ludvigsson P, Hesdorffer D, Olafsson E, Kjartansson O, Hauser WA. Migraine with aura is a risk factor for unprovoked seizures in children. Ann Neurol 2006;59:210-3.
65. Ottman R, Lipton RB. Comorbidity of migraine and epilepsy. Neurology 1994;44:2105-10.
66. Baumeister H, Balke K, Härter M. Psychiatric and somatic comorbidities are negatively associated with quality of life in physically ill patients. J Clin Epidemiol 2005;58:1090-100.
67. Gilliam F, Hecimovic H, Sheline Y. Psychiatric comorbidity, health, and function in epilepsy. Epilepsy Behav 2003;4(Suppl. 4):S26-30.
68. Johnson EK, Jones JE, Seidenberg M, Hermann BP. The relative impact of anxiety, depression, and clinical seizure features on health-related quality of life in epilepsy. Epilepsia 2004;45:544-50.
69. Hinnell C, Williams J, Metcalfe A et al. Health status and health-related behaviors in epilepsy compared to other chronic conditions - a national population-based study. Epilepsia 2010;51:853-61.
70. Taylor RS, Sander JW, Taylor RJ, Baker GA. Predictors of health-related quality of life and costs in adults with epilepsy: a systematic review. Epilepsia 2011;52:2168-80.
71. Perucca P, Gilliam FG, Schmitz B. Epilepsy treatment as a predeterminant of psychosocial ill health. Epilepsy Behav 2009;15(Suppl. 1):S46-50.
72. Mattson RH, Cramer JA, Collins JF et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 1985;313:145-51.
73. Karceski SC. Seizure medications and their side effects. Neurology 2007;69:E27-9.
74. Luoni C, Bisulli F, Canevini MP; SOPHIE Study Group et al. Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients usingvalidated quantitative assessments. Epilepsia 2011;52:2181-91.
75. Boylan LS, Flint LA, Labovitz DL, Jackson SC, Starner K, Devinsky O. Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy. Neurology 2004;62:258-61.
76. Jacoby A, Gamble C, Doughty J, Marson A, Chadwick D; Medical Research Council MESS Study Group. Quality of life outcomes of immediate or delayed treatment of early epilepsy and single seizures. Neurology 2007;68:1188-96.
77. O'Donoghue MF, Goodridge DM, Redhead K, Sander JW, Duncan JS. Assessing the psychosocial consequences of epilepsy: a community-based study. Br J Gen Pract 1999;49:211-4.
78. Sillanpää M, Haataja L, Shinnar S. Perceived impact of childhood-onset epilepsy on quality of life as an adult. Epilepsia 2004;45:971-7.
79. Jacoby A. Felt versus enacted stigma: a concept revisited. Evidence from a study of people with epilepsy in remission. Soc Sci Med 1994;38:269-74.
80. Baker GA, Smith DF, Dewey M, Jacoby A, Chadwick DW. The initial development of a health-related quality of life model as an outcome measure in epilepsy. Epilepsy Res 1993;16:65-81.
81. Cramer JA. Quality of life for people with epilepsy. Neurol Clin 1994;12:1-13.
82. Cramer JA. Quality of life as an outcome measure for epilepsy clinical trials. Pharm World Sci 1997;19:227-30.
83. Cramer JA; ILAE Subcommission on Outcome Measurement in Epilepsy. Principles of health-related quality of life: assessment in clinical trials. Epilepsia 2002;43:1084-95.
84. Leone MA, Beghi E, Righini C, Apolone G, Mosconi P. Epilepsy and quality of life in adults: a review of instruments. Epilepsy Res 2005;66:23-44.
85. Baker GA, Frances P, Middleton E. Initial development, reliability, and validity of a patient-based adverse events scale. Epilepsia 1994;35(Suppl. 7):80 (abstract).
86. Gilliam FG, Fessler AJ, Baker G, Vahle V, Carter J, Attarian H. Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial. Neurology 2004;62:23-7.
87. Montgomery SA, Åsberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-9.
88. Ross J, Stefan H, Schäuble B, Day R, Sander JW. European survey of the level of satisfaction of patients and physicians in the management of epilepsy in general practice. Epilepsy Behav 2010;19:36-42.
89. Thomas RH, Hammond CL, Bodger OG, Rees MI, Smith PE; members of WERN & James Lind Alliance. Identifying and prioritising epilepsy treatment uncertainties. J Neurol Neurosurg Psychiatry 2010;81:918-21.
90. Baker GA, Hargis E, Hsih MM; International Bureau for Epilepsy et al. Perceived impact of epilepsy in teenagers and young adults: an international survey. Epilepsy Behav 2008;12:395-401.
91. Sare G, Rawnsley M, Stoneman A, Duncan S. Men with epilepsy - the lost tribe? Results of a nationwide survey of men with epilepsy living in the UK. Seizure 2007;16:384-96.
92. Cramer JA, Dupont S, Goodwin M, Trinka E. What really matters to people with epilepsy in 2011? A pan-European patient survey. Epilepsia 2011;52(Suppl. 6):23 (abstract p055).